Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients
Ioannis P. Trougakos(National and Kapodistrian University of Athens), Meletios Α. Dimopoulos(Korea University), Ioannis Papassotiriou(National and Kapodistrian University of Athens), Efstathios Kastritis(National and Kapodistrian University of Athens), Christine‐Ivy Liacos(National and Kapodistrian University of Athens), Sentiljana Gumeni(National and Kapodistrian University of Athens), Evangelos Terpos(National and Kapodistrian University of Athens), Eleni Korompoki(National and Kapodistrian University of Athens), Ioanna Charitaki(National and Kapodistrian University of Athens), Eleni‐Dimitra Papanagnou(National and Kapodistrian University of Athens), Christina Zirou(Sotiria General Hospital), Aimilia D. Sklirou(National and Kapodistrian University of Athens), Filia Apostolakou(Children's Hospital Agia Sophia), Andreas Scorilas(National and Kapodistrian University of Athens), Tina Bagratuni(National and Kapodistrian University of Athens)
Cited by 59
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k